Suchergebnisse - "Antibodies, Monoclonal, Humanized"

PubPharm (8.118)

1

Impact of body mass index on the prognosis of unresectable HCC patients receiving first-line Lenvatinib or atezolizumab plus bevacizumab

enthalten in: Liver international : official journal of the International Association for the Study of the Liver | 2024

von Rimini, M. | Stefanini, B. | Tada, T. | +75

2

Radio-pathomic maps of glioblastoma identify phenotypes of non-enhancing tumor infiltration associated with bevacizumab treatment response

enthalten in: Journal of neuro-oncology | 2024

von Bobholz, S. | Hoefs, A. | Hamburger, J. | +9

UpdateOf: Res Sq. 2024 Jan 08;:. - PMID 38260400

3

Phase III, Randomized Study of Atezolizumab Plus Bevacizumab and Chemotherapy in Patients With EGFR- or ALK-Mutated Non-Small-Cell Lung Cancer (ATTLAS, KCSG-LU19-04)

enthalten in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology | 2024

von Park, S. | Kim, T. | Han, J. | +21

4

Clinical usefulness of newly developed prognostic predictive score for atezolizumab plus bevacizumab for hepatocellular carcinoma

enthalten in: Cancer reports (Hoboken, N.J.) | 2024

von Ohama, H. | Hiraoka, A. | Tada, T. | +42

5

Atezolizumab plus bevacizumab in advanced Merkel cell carcinoma : A prospective study

enthalten in: Oral oncology | 2024

von de Sousa, L. | Liu, S. | Bhosale, P. | +16

6

Changing from NAFLD to MASLD : Similar prognosis of patients with HCC under atezolizumab/bevacizumab treatment between NAFLD and MASLD

enthalten in: Clinical and molecular hepatology | 2024

von Suzuki, H. | Shimose, S. | Iwamoto, H. | +2

7

Global phase 3 results show that bevacizumab with immunotherapy has activity in liver cancer

enthalten in: Cancer | 2024

von Nierengarten, M.

8

Short Term Effect of Pre-Operative Anti-VEGF on Angiogenic and Fibrotic Profile of Fibrovascular Membranes of Proliferative Diabetic Retinopathy

enthalten in: Investigative ophthalmology & visual science | 2024

von Fadakar, K. | Rahmani, S. | Tedeschi, T. | +2

9

Off-label use of intravitreal bevacizumab : A global conundrum

enthalten in: Indian journal of ophthalmology | 2024

von Singh, S. | Saxena, S. | Akduman, L. | +1

10

Pathological complete response of hepatocellular carcinoma confirmed by conversion hepatectomy following atezolizumab plus bevacizumab therapy : a case report and literature review

enthalten in: Clinical journal of gastroenterology | 2024

von Sato, S. | Aoki, T. | Matsumoto, T. | +7

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[812]